undamentalytics Newsletter

Globus Medical vs Revvity

Globus Medical and Revvity are similar in size: $2.94bn and $2.86bn of revenue in their latest fiscal years. Globus Medical grew faster (16.7% against 3.7%). Globus Medical kept more of each dollar of sales as profit: a net margin of 18.3% against 8.4%.

Latest fiscal yearGlobus MedicalGMED, 2025RevvityRVTY, 2025
Revenue $2.94bn $2.86bn
Revenue growth 16.7% 3.7%
Net income $538m $241m
Operating margin — 12.5%
Net margin 18.3% 8.4%
Return on equity 12.3% 3.2%
Free cash flow $589m $509m
Cash $526m $920m
Total debt $0 $3.24bn
Debt to equity — 44.7%
Dividend per share — $0.28
Dividend yield — 0.2%
Share buybacks $300m $821m
Employees 6,000 11,000
Market value $10.94bn $18.57bn
Price vs our value range Below our value range Above our value range
Moat score 71 (Strong) 70 (Moderate)
Insider trades, 12 months 0 buys, 14 sales 0 buys, 17 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.